401(k) · DOL Form 5500 · 2023

Celldex Therapeutics, Inc. 401(k) Plan

Data updated 2026-08-11

$50M
Total assets
147
Participants
85th
Percentile by assets
$338,314
Avg per participant
PlainRetire home → About this data

Official DOL plan name: Celldex Therapeutics, Inc. Employee Savings Plan · Sponsored by Celldex Therapeutics, Inc. · Massachusetts · Manufacturing

$50M in assets, 147 participants

Celldex Therapeutics, Inc.'s Celldex Therapeutics, Inc. Employee Savings Plan reported $50M in total assets and 147 participants in its 2023 DOL Form 5500 filing, ranking in the 85th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • 85th percentile by assets (of 127,072 plans)
  • #14,785 in Manufacturing (18,722 peers)

Coverage in Massachusetts

Celldex Therapeutics, Inc. Employee Savings Plan covers 147 participants in Massachusetts, about 22% of the average Massachusetts filer (state average ~659 per filing). Assets: $50M.

$50M
total plan assets (2023 EOY)
147
covered participants
85th
percentile by assets (of 127,072 plans)
$338,314
avg assets per participant

Where Celldex Therapeutics, Inc. Employee Savings Plan sits by total assets

Celldex Therapeutics, Inc. Employee Savings Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$49,732,223 Top 15% higher than 85% of 127,068 filed plans

This plan $0 $2,010,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Celldex Therapeutics, Inc. Employee Savings Plan reported net income rose from -$12M in the plan year 2022 filing to $7M in the plan year 2023 filing.
  • Celldex Therapeutics, Inc. Employee Savings Plan end-of-year assets rose from $42M in the plan year 2022 filing to $50M in the plan year 2023 filing.
  • Celldex Therapeutics, Inc. Employee Savings Plan reported participants rose from 134 in the plan year 2022 filing to 147 in the plan year 2023 filing.

See the national 2022→2023 release diff →

State
Massachusetts
Industry
Manufacturing

Participants vs Massachusetts filers

In Massachusetts, the average filing covers about 659 participants across 4,265 plans. Celldex Therapeutics, Inc. Employee Savings Plan reports 147 participants - about 22% of that state average ($50M EOY assets).

Massachusetts filing particulars

Total Assets (Beginning of Year)$42M
Net Assets (End of Year)$50M
Net Income$7M
Employer EIN133191702
Plan Effective Date1990-05-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Celldex Therapeutics, Inc.)

$40M$45M$50M$55M$60M 202220232024 $42.3M $57.7M ▲ +36.7%
Total plan assets by year, all Celldex Therapeutics, Inc. plans on file
Year Plans Participants Total Assets
2022 1 134 $42M
2023 1 147 $50M
2024 1 159 $58M

Nearby 401(k) Plans in Massachusetts

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Celldex Therapeutics, Inc. Employee Savings Plan vs. nearby 401(k) plans in Massachusetts, assets vs. participants Scatter plot of 6 data points. -20000020000400006000080000 -10010203040 Total assets ($B) Participants Celldex Therapeutics…, Total assets ($B): 0.049732223 · Participants: 147Celldex Therapeutics…Fidelity Retirement …, Total assets ($B): 28.649852331 · Participants: 62289Fidelity Retirement …Liberty Mutual 401(k…, Total assets ($B): 10.556596852 · Participants: 37052Liberty Mutual 401(k…Massachusetts Instit…, Total assets ($B): 6.829912863 · Participants: 14094Massachusetts Instit…Boston Scientific Co…, Total assets ($B): 5.786107181 · Participants: 19881Boston Scientific Co…Philips North Americ…, Total assets ($B): 5.779286156 · Participants: 19120Philips North Americ…
Celldex Therapeutics, Inc. Employee Savings Plan vs. nearby 401(k) plans in Massachusetts, assets vs. participants
Compare Celldex Therapeutics, Inc. Employee Savi… side-by-side with 3 peers →

Similar-Sized 401(k) Plans Nationally

401(k) plans in other states closest to Celldex Therapeutics, Inc. Employee Savings Plan by total assets, not by location.

Frequently Asked Questions

How did Celldex Therapeutics, Inc. Employee Savings Plan assets move in 2023? ▼
Celldex Therapeutics, Inc. Employee Savings Plan grew sharply - up 17.7% during 2023, from $42M to $50M. Reported net income was $7M.
How have Celldex Therapeutics, Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Celldex Therapeutics, Inc.'s sponsor-wide assets grew 36.6%, from $42M to $58M.
Where does Celldex Therapeutics, Inc. Employee Savings Plan rank by assets among Form 5500 filers? ▼
Celldex Therapeutics, Inc. Employee Savings Plan ranks in the 85th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Celldex Therapeutics, Inc. Employee Savings Plan? ▼
Among 401(k) plans in other states, the closest by assets is Associates' Savings Plan in FL ($50M, 465 participants).

Next read for Celldex Therapeutics, Inc. Employee Savi…

Filing takeaways

Ways to act on Celldex Therapeutics, Inc. Employee Savings Plan's numbers.

  • By total assets, Celldex Therapeutics, Inc. Employee Savings Plan ranks in the top quartile of all filed plans by assets. See the largest plans
  • Compare it side-by-side against 3 similar 401(k) plans in Massachusetts. Compare plans
  • Celldex Therapeutics, Inc.'s sponsor-wide assets have grown 36.6% since 2022 across 3 plan years on file. More Manufacturing plans

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 133191702.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.